Abstract:Ischaemic stroke causes neuron loss and long-term functional deficits. Unfortunately, effective approaches to preserving neurons and promoting functional recovery remain unavailable. Oligodendrocytes, the myelinating cells in the CNS, are susceptible to oxygen and nutrition deprivation and undergo degeneration after ischaemic stroke. Technically, new oligodendrocytes and myelin can be generated by the differentiation of oligodendrocyte precursor cells (OPCs). However, myelin dynamics and their functional significance after ischaemic stroke remain poorly understood. Here, we report numerous denuded axons accompanied by decreased neuron density in sections from ischaemic stroke lesions in human brain, suggesting that neuron loss correlates with myelin deficits in these lesions.To investigate the longitudinal changes in myelin dynamics after stroke, we labelled and traced pre-existing and newly-formed myelin, respectively, using cell-specific genetic approaches. Our results indicated massive oligodendrocyte death and myelin loss 2 weeks after stroke in the transient middle cerebral artery occlusion (tMCAO) mouse model. In contrast, myelin regeneration remained insufficient 4 and 8 weeks post-stroke. Notably, neuronal loss and functional impairments worsened in aged brains, and new myelin generation was diminished.To analyse the causal relationship between remyelination and neuron survival, we manipulated myelinogenesis by conditional deletion of Olig2 (a positive regulator) or muscarinic receptor 1 (M1R, a negative regulator) in OPCs. Deleting Olig2 inhibited remyelination, reducing neuron survival and functional recovery after tMCAO. Conversely, enhancing remyelination by M1R conditional knockout or treatment with the pro-myelination drug clemastine after tMCAO preserved white matter integrity and neuronal survival, accelerating functional recovery. Together, our findings demonstrate that enhancing myelinogenesis is a promising strategy to preserve neurons and promote functional recovery after ischaemic stroke. Cheng et al. reveal myelin deficits in human brain sections after ischaemic stroke. In a mouse model of stroke, a failure of myelin regeneration potentiates neuronal loss and functional impairments, while a pro-myelination drug helps preserve white matter integrity and promotes neuronal survival and functional recovery.See Vagionitis et al. (https://doi.org/10.1093/brain/awae080) for a scientific commentary on this article.

Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy

Microglia: A Potential Drug Target for Traumatic Axonal Injury

Therapeutic Potential of Cytokines in Demyelinating Lesions After Stroke

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?

Damage Mechanisms to Oligodendrocytes and White Matter in Central Nervous System Injury: The Australian Context

Traumatic white matter injury and glial activation: from basic science to clinics.

Traumatic Brain Injury: Crosstalk Between ER and Mitochondria Contributes to Oligodendrocyte Cell Death and Demyelination

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Progress of Researches on the Mechanism of the Role of Nonspecific Inflammation Mediatedby Microglia Activation in the White Matter Demyelination of Vascular Cognitive Impairment

Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases

Cell-based remyelinating therapy in inflammatory demyelinating injury of the CNS

Prolonged Myelin Deficits Contribute to Neuron Loss and Functional Impairments after Ischaemic Stroke.

Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair after Ischemic Stroke

[Advances in molecular mechanisms and therapeutic strategies of white matter injury after intracerebral hemorrhage]

Damage to Myelin and Oligodendrocytes: A Role in Chronic Outcomes Following Traumatic Brain Injury?

Dynamics of Microglia Activation in the Ischemic Brain: Implications for Myelin Repair and Functional Recovery

443 Myeloid Immunometabolic Reprogramming Mitigates Chronic Neurodegeneration After Experimental Traumatic Brain Injury

Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities

Novel microglia-mediated mechanisms underlying synaptic loss and cognitive impairment after traumatic brain injury